Biotechnology

Ziopharm Oncology

$3.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.55%) As of 4:22 PM UTC today

Why Robinhood?

You can buy or sell ZIOP and other stocks, options, and ETFs commission-free!

About ZIOP

ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA. The listed name for ZIOP is ZIOPHARM Oncology Inc Common Stock.

CEO
Laurence James Neil Cooper
Employees
73
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
803.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.70M
High Today
$3.70
Low Today
$3.56
Open Price
$3.65
Volume
420.81K
52 Week High
$4.44
52 Week Low
$1.80

Collections

ZIOP Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, After Hours

You May Also Like

OLED
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure